Table 6: Main product based on Novasorb technology marketed or to be marketed.

ProductActive ingredientIndicationStatus

CationormMedical deviceDry eyeMarketed
Cyclokat0.1% cyclosporine ASevere dry eyePhase III
Vekacia0.1% cyclosporine AVernal
keratoconjunctivitis
Phase III
Catioprost0.005% latanoprostGlaucoma associated with ocular surface diseasePhase II